The prognostic value of admission red cell distribution width-to-platelet ratio in XXXX with @entity583 undergoing primary percutaneous coronary intervention.

@entity1 @entity712 @entity74 @entity583 @entity1455 @entity65
OBJECTIVE: Red cell distribution width (RDW) is a measure of variation in the size of circulating red blood cells. Recent studies have reported a strong independent relation between elevated RDW and short- and long-term prognosis in @entity74 . The aim of the present study was to investigate the relationship between admission RDW-to-platelet ratio (RPR) and in-hospital and long-term prognosis in @entity1 with @entity583 ( @entity583 ) undergoing primary percutaneous coronary intervention (PCI). METHODS: A total of 470 consecutive @entity1 with a diagnosis of @entity583 who underwent primary PCI were included in this prospective study. The @entity1 were divided into two groups based on their admission RPR: high (>0.061) RPR group and low ( <=0.061) RPR group. The @entity1 were followed for adverse clinical outcomes in-hospital and for up to one year after discharge. RESULTS: In-hospital @entity65 , major adverse cardiovascular events (MACE), advanced @entity712 and @entity1455 were significantly higher in the high RPR group (p<0.05). All-cause and @entity65 , MACE, fatal reinfarction, advanced @entity712 , and rehospitalization for cardiac cause were more frequent in the high RPR group in one-year follow-up (p<0.05). High RPR was found to be a significant independent predictor of one-year @entity65 in multivariate analysis (p=0.003, OR: 3.106, 95% CI: 1.456-6.623). CONCLUSION: RPR is an inexpensive and readily available biomarker that provides an additional level of risk stratification beyond that provided by conventional risk parameters in predicting long-term MACE and @entity65 in @entity583 .
